This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Michael Gutschow: Innovator in Angiogenesis Inhibition
Introduction
Michael Gutschow is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of medical science, particularly in the area of angiogenesis inhibition. His work focuses on developing novel compounds that can effectively inhibit neoplasms and undesired angiogenesis.
Latest Patents
Gutschow holds a patent for "Tetrahalogenated compounds useful as inhibitors of angiogenesis." This patent outlines methods for inhibiting a neoplasm in a subject and describes the administration of a therapeutically effective amount of at least one novel tetrahalogenated compound, or a pharmaceutically acceptable salt thereof. He has 1 patent to his name, showcasing his innovative approach to tackling complex medical challenges.
Career Highlights
Throughout his career, Gutschow has worked with various esteemed organizations. Notably, he has collaborated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has contributed to advancements in medical research and therapeutic applications.
Collaborations
Gutschow has had the opportunity to work alongside prominent professionals in his field, including William Douglas Figg and Agnieszka Ambrozak. These collaborations have further enriched his research and development efforts.
Conclusion
Michael Gutschow's innovative work in the field of angiogenesis inhibition highlights his commitment to advancing medical science. His contributions through patents and collaborations reflect his dedication to improving therapeutic options for patients.